589 related articles for article (PubMed ID: 10936974)
21. Comparison of immunogenicity of two hepatitis A vaccines--VAQTA and HAVRIX--in young adults.
Ashur Y; Adler R; Rowe M; Shouval D
Vaccine; 1999 May; 17(18):2290-6. PubMed ID: 10403597
[TBL] [Abstract][Full Text] [Related]
22. Safety and effectiveness of the new inactivated hepatitis A virus vaccine.
Furesz J; Scheifele DW; Palkonyay L
CMAJ; 1995 Feb; 152(3):343-8. PubMed ID: 7828098
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis A vaccination of Argentinean infants: comparison of two vaccination schedules.
López EL; Contrini MM; Xifró MC; Cattaneo MA; Zambrano B; Dumas R; Rouyrre N; Weber F
Vaccine; 2007 Jan; 25(1):102-8. PubMed ID: 16914234
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis A vaccination of infants: effect of maternal antibody status on antibody persistence and response to a booster dose.
Fiore AE; Shapiro CN; Sabin K; Labonte K; Darling K; Culver D; Bell BP; Margolis HS
Pediatr Infect Dis J; 2003 Apr; 22(4):354-9. PubMed ID: 12690277
[TBL] [Abstract][Full Text] [Related]
25. Immunogenicity of an inactivated hepatitis A pediatric vaccine: three-year post-booster follow-up.
Dagan R; Greenberg D; Weber F
Vaccine; 2005 Oct; 23(44):5144-8. PubMed ID: 16043271
[TBL] [Abstract][Full Text] [Related]
26. Immunogenicity of hepatitis A-inactivated vaccine administered to seronegative infants, and serological follow-up 12 months after second dose.
De Silvestri A; Zara F; Terulla V; Brerra R; Zucca S; Belloni C
Acta Paediatr; 2006 Dec; 95(12):1582-5. PubMed ID: 17129966
[TBL] [Abstract][Full Text] [Related]
27. [Studies on immunization strategy against hepatitis A in a highly prevalent area].
Zhang Y; Ma J; Zhao S
Zhonghua Yu Fang Yi Xue Za Zhi; 1998 Sep; 32(5):295-6. PubMed ID: 10322776
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of inactivated hepatitis A vaccine in Canadians 40 years of age or more.
Scheifele DW; Bjornson GJ
CMAJ; 1993 Feb; 148(4):551-5. PubMed ID: 8431816
[TBL] [Abstract][Full Text] [Related]
29. A two dose combined hepatitis A and B vaccine in Chinese youngsters.
Lee SD; Chan CY; Yu MI; Wang YJ; Chang FY; Lo KJ; Safary A
J Med Virol; 1999 Sep; 59(1):1-4. PubMed ID: 10440800
[TBL] [Abstract][Full Text] [Related]
30. Analysis of the antibody response in humans with a new inactivated hepatitis A vaccine.
Vidor E; Xueref C; Blondeau C; Bajard A; Francon A; Goudeau A; Peyron F; Brasseur P; Zuckerman A
Biologicals; 1996 Sep; 24(3):235-42. PubMed ID: 8978923
[TBL] [Abstract][Full Text] [Related]
31. Concomitant administration of a virosome-adjuvanted hepatitis a vaccine with routine childhood vaccines at age twelve to fifteen months: a randomized controlled trial.
Dagan R; Amir J; Livni G; Greenberg D; Abu-Abed J; Guy L; Ashkenazi S; Foresner G; Tewald F; Schätzl HM; Hoffmann D; Ibanez R; Herzog C
Pediatr Infect Dis J; 2007 Sep; 26(9):787-93. PubMed ID: 17721372
[TBL] [Abstract][Full Text] [Related]
32. [Safety and immunogenicity of Bilive combined hepatitis A and B vaccine].
Zhao YL; Chen YG; Li J; Han GX; Tian C; Liang JL; Li G; Wang ZG; Zhu YG; Tian ZN; Zhang HY; Wan ZJ; Liang ZL; Bi SL
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun; 25(6):470-3. PubMed ID: 15231119
[TBL] [Abstract][Full Text] [Related]
33. Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C.
Kallinowski B; Jilg W; Buchholz L; Stremmel W; Engler S
Z Gastroenterol; 2003 Oct; 41(10):983-90. PubMed ID: 14562195
[TBL] [Abstract][Full Text] [Related]
34. Inactivated hepatitis A vaccine: reactogenicity, immunogenicity, and long-term antibody persistence.
Van Damme P; Thoelen S; Cramm M; De Groote K; Safary A; Meheus A
J Med Virol; 1994 Dec; 44(4):446-51. PubMed ID: 7897379
[TBL] [Abstract][Full Text] [Related]
35. [Vaccination against hepatitis A].
Balli F; Di Biase AR; Viola L
Pediatr Med Chir; 1996; 18(3):259-62. PubMed ID: 8966125
[TBL] [Abstract][Full Text] [Related]
36. Immunogenicity of an inactivated hepatitis A vaccine in infants and young children.
Bell BP; Negus S; Fiore AE; Plotnik J; Dhotre KB; Williams J; Shapiro CN; McMahon BJ
Pediatr Infect Dis J; 2007 Feb; 26(2):116-22. PubMed ID: 17259872
[TBL] [Abstract][Full Text] [Related]
37. Interchangeability and tolerability of two inactivated hepatitis A vaccines in Chinese children.
Zhang ZL; Zhu XJ; Wang X; Liang M; Sun J; Liu Y; Gao ZG; Wu JY; Dong XJ; Liu RK; Chen JT; Zhang YQ; Wang W; Zhang LP; Yin W
Vaccine; 2012 Jun; 30(27):4028-33. PubMed ID: 22537990
[TBL] [Abstract][Full Text] [Related]
38. [Comparison of two different vaccination schemes against Hepatitis A and B in Mexican children and adolescents].
González-Huezo MS; Sánchez-Avila F; García Mayol M; Castro Narro G; Sixtos S; Lisker-Melman M; Kershenobich D
Rev Gastroenterol Mex; 2003; 68(4):271-6. PubMed ID: 15125329
[TBL] [Abstract][Full Text] [Related]
39. Hepatitis A booster vaccine in children after infant immunization.
Kanra G; Yalcin SS; Kara A; Ozmert E; Yurdakök K
Pediatr Infect Dis J; 2002 Aug; 21(8):727-30. PubMed ID: 12192159
[TBL] [Abstract][Full Text] [Related]
40. Reactogenicity and immunogenicity profile of a two-dose combined hepatitis A and B vaccine in 1-11-year-old children.
Roberton D; Marshall H; Nolan TM; Sokal E; Díez-Domingo J; Flodmark CE; Rombo L; Lewald G; Flor Jde L; Casanovas JM; Verdaguer J; Marés J; Esso DV; Dieussaert I; Stoffel M
Vaccine; 2005 Oct; 23(43):5099-105. PubMed ID: 16055231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
